Magellan Health (MGLN)

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Company profile

Ticker

MGLN

Exchange

NASDAQ

Website

www.magellanhealth.com

CEO

Kenneth J. Fasola

Incorporated

Delaware

Location

Arizona

Fiscal year end

Dec 31

Sector

Health Care and Social Assistance > HMO Medical Centers

Industry (SIC)

Services - Hospitals

MEDNAX • Encompass Health • Select Medical • JRSIS HEALTH CARE • New Frontier Health • Bitech Technologies ...

Former names

CHARTER MEDICAL CORP, MAGELLAN HEALTH SERVICES INC

SEC CIK

0000019411

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Magellan Pharmacy Services, Inc. • AdvoCare of Tennessee, Inc. • Magellan Method, LLC • Magellan Administrative Services, LLC • Magellan Behavioral Health of New Jersey, LLC • Magellan Behavioral of Michigan, Inc. • Magellan Health Services of California, Inc. • Magellan Rx Management IPA, Inc. • Magellan Rx Pharmacy, LLC • ONCORE Healthcare, LLC ...

IRS number

581076937

MGLN stock data

1M 1Y 5Y

Press releases

From Benzinga Pro

Magellan Healthcare Provides Resources in Support of BIPOC Mental Health Awareness Month in July

24 Jun 22

Magellan Healthcare, the behavioral and specialty healthcare segment of Magellan Health, Inc., today announced resources and programs in support of Black, Indigenous and People of Color (BIPOC) Mental Health Awareness

Magellan Healthcare Provides Resources to Address Growing Needs and Bring Awareness During Mental Health Month

28 Apr 22

Featuring a collaboration with Inspiring My Generation to promote its Encouragement Card Program for the community to make encouragement cards for adults and youth hospitalized in mental health facilities Magellan

Magellan Healthcare Announces New Collaboration with Concert Genetics to Improve Genetic Testing

25 Apr 22

New end-to-end Genetic Testing Solution addresses overpayments and waste while driving value for providers, payers, and members Magellan Healthcare, the behavioral health and specialty division of Magellan Health,

Calendar

5 Nov 21

26 Jun 22

31 Dec 22

Financial summary

Financial statements Chart MGLN financial data

Quarter (USD)	Sep 21	Jun 21	Mar 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.04B	1.04B	1.04B	1.04B	1.04B	1.04B
Cash burn (monthly)	(no burn)	(no burn)	(no burn)	319.08K	(no burn)	(no burn)
Cash used (since last report)	n/a	n/a	n/a	2.84M	n/a	n/a
Cash remaining	n/a	n/a	n/a	1.04B	n/a	n/a
Runway (months of cash)	n/a	n/a	n/a	3245.6	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

MGLN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares
4 Jan 22	Abbott Swati Bargotra	Ordinary Common Stock, $0.01 par value	Sale back to company	Dispose D	No	No	6,847
4 Jan 22	David Bourdon	Ordinary Common Stock, $0.01 par value	Sale back to company	Dispose D	No	No	1,330
4 Jan 22	David Bourdon	RSU Common Stock	Sale back to company	Dispose D	No	No	4,362
4 Jan 22	David Bourdon	RSU Common Stock	Sale back to company	Dispose D	No	No	16,963
4 Jan 22	David Bourdon	RSU Common Stock	Sale back to company	Dispose D	No	No	4,383
4 Jan 22	Kenneth J Fasola	Ordinary Common Stock, $0.01 par value	Sale back to company	Dispose D	No	No	17,141
4 Jan 22	Kenneth J Fasola	RSU Common Stock	Sale back to company	Dispose D	No	No	27,743
4 Jan 22	Kenneth J Fasola	RSU Common Stock	Sale back to company	Dispose D	No	No	18,411
4 Jan 22	Kenneth J Fasola	RSU Common Stock	Sale back to company	Dispose D	No	No	43,080
4 Jan 22	Kenneth J Fasola	RSU Common Stock	Sale back to company	Dispose D	No	No	22,196

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

MGLN institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	174	-98.9%
Opened positions	0	23	EXIT
Closed positions	172	25	+588.0%
Increased positions	0	60	EXIT
Reduced positions	1	59	-98.3%

13F shares	Current	Prev Q	Change
Total value	106K	4.7B	-100.0%
Total shares	1.14K	26.3M	-100.0%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Ancora Advisors	1K	$93K	-43.2%
Allspring Global Investments	142	$13K	0.0%
Starboard Value	0	$0	EXIT

Largest transactions	Bought/sold	Change
BLK Blackrock	-3.87M	EXIT
Vanguard	-2.54M	EXIT
Starboard Value	-2.37M	EXIT
Ubs Oconnor	-1.74M	EXIT
Dimensional Fund Advisors	-1.27M	EXIT
Magnetar Financial	-1.24M	EXIT
MS Morgan Stanley	-1.2M	EXIT
STT State Street	-900.84K	EXIT
Alpine Associates Management	-770.5K	EXIT
Arp Americas	-734.78K	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Cigna

Management Discussion

Net revenue, cost of care, cost of goods sold, and direct service costs and other operating expense variances are addressed within the segment results that follow.
Depreciation and amortization expense decreased by 10.9 percent or $12.0 million from 2019 to 2020, primarily due to asset maturities and office impairments, partially offset by normal asset additions in the current year.
Interest expense decreased by $5.0 million from 2019 to 2020 primarily due to lower interest rates and lower debt balances.